Impact of minimally invasive gastrectomy on use of and time to adjuvant chemotherapy for gastric adenocarcinoma.
Norma E FarrowKyle W FreischlagMohamed A AdamDan G BlazerPublished in: Journal of surgical oncology (2020)
In this study, while MIS for gastric adenocarcinoma was associated with shorter hospital stays and comparable survival, it was not associated with improved utilization or time to initiation of adjuvant chemotherapy.